Armistice AUM Growth Reflected in Strategic Ocular Research Investment Portfolio
The landscape of biotech investment has undergone notable shifts, with some therapeutic regions garnering particular attention from institutional investors and hedge funds. While obesity-related drug research has captured significant market interest, as evidenced by Morgan Stanley Research’s substantial $39 billion increase in its six-year market forecast, the ophthalmic sector has emerged as another compelling area […]